You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Grade MDS/MPN

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

Recruiting
  • High Grade Myelodysplastic Syndromes
  • Aurora, Colorado
    Universtiy of Colorado Denver
Nov 17, 2022

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

Not yet recruiting
  • Myeloid Malignancies
  • +3 more
  • (no location specified)
Mar 22, 2023

Acute Myeloid Leukemia Trial in Gainesville (Integrative Therapy)

Suspended
  • Acute Myeloid Leukemia
  • Integrative Therapy
  • Gainesville, Florida
    University of Florida
Sep 13, 2022

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

AML, MDS Trial in United States (APVO436)

Recruiting
  • AML
  • MDS
  • APVO436
  • San Francisco, California
  • +11 more
Feb 8, 2022

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

Recruiting
  • MDS/MPN
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2022

Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

Enrolling by invitation
  • Myelodysplastic/Myeloproliferative Neoplasms
  • Adult
  • venetoclax combined with azacitidine
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Mar 7, 2022

Action of Interferon in Treatment of Myeloproliferative

Recruiting
  • Myeloproliferative Neoplasm
    • Villejuif, Ile De France, France
      Inserm U1287
    Apr 28, 2023

    MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 16, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +2 more
    • Clofarabine 40mg/m^2
    • +5 more
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 3, 2020

    The National Myelodysplastic Syndromes (MDS) Study

    Recruiting
    • Myelodysplastic Syndromes (MDS)
    • Therapeutic
    • Anaheim, California
    • +280 more
    Apr 8, 2022

    Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

    Recruiting
    • Iron Deficiency Anemia
    • Adelaide, South Australia, Australia
    • +8 more
    Jun 23, 2023

    Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

    Not yet recruiting
    • Myelofibrosis (PMF)
    • +2 more
    • New York, New York
      Ruttenberg Treatment Center
    Apr 18, 2023

    Hematological Malignancies - SANGUINE

    Recruiting
    • Hematologic Malignancy
    • Blood sampling for HemaChip screening/diagnostic testing
    • Bone marrow sampling
    • Olomouc, Czechia
    • +3 more
    Feb 9, 2023

    Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Houston, Texas
    • +23 more
    Aug 18, 2022

    MDS, Ferroptosis Trial in Pessac (Biological sampling)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Ferroptosis
    • Biological sampling
    • Pessac, France
    • +2 more
    Jun 19, 2023

    MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

    Recruiting
    • Myelodysplastic Syndromes, de Novo
    • +10 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 23, 2023

    Minimal Residual Disease of Acute Myelogenous Leukemia or High

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
      • Rochester, New York
        University of Rochester Medical Center
      May 3, 2022

      MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • Aachen, NRW, Germany
      • +2 more
      Mar 29, 2023

      Hematologic Malignancy Trial in Guangzhou (BC3402 Injection)

      Not yet recruiting
      • Hematologic Malignancy
      • BC3402 Injection
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital of Jinan University
      Jan 10, 2023

      AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

      Not yet recruiting
      • AML/MDS
      • +2 more
      • (no location specified)
      Aug 14, 2023